Loading...
HomeMy WebLinkAboutNCG060105_Delegation of Signature Authority_202009300 29 September 2020 Permitting Authority NCDEQ, Division of Water Quality Attn: Bethany Georgoulias 1617 Mail Service Center Raleigh, NC 27699-1617 Subject: Delegation of Signatory Authority for Reports I, Laurie Braxton, Site Director of GlaxoSmithKline — Zebulon, NC (the "Company") do hereby approve of Jim Kenny, EHS Director, and David Schaefer, EHS Engineer, to be "Authorized Representatives" for all signatory requirements related to reports required by the general permit as stated in Part lll: Standard Conditions, Section B: General Conditions, 5.(b)(2) in our general permit NCG060000, certificate of coverage NCG060105. Sincerely, Laurie Braxton VP & Site Director GSK 1011 N. Arendell Avenue Zebulon, North Carolina 27597 Georgoulias, Bethany From: David Schaefer <david.x.schaefer@gsk.com> Sent: Wednesday, September 30, 2020 12:11 PM To: Georgoulias, Bethany Subject: [External] GSK Zebulon NCG060105 - new Site Director / Delegation of signature authority Attachments: delegation of authority letter to NCDEQ Jim Kenny Dave Schaefer - L. Braxton.pdf • 1 External email. Do not click links or open attachments unless you verify. Send all suspicious email as an attachment to ort.s am nc. ov Hi Bethany, I wanted to let you know that our site has a new director, so I've had this new letter of delegation drafted and signed. I had planned to send the hard copy with our Period 2 quantitative monitoring data report which will be in the next week or two. Please let me know if you'd prefer me to send the hard copy separately and I'd be happy to do so. Thanks, David Schaefer, CHMM EHS Engineer Safety Manufacturing GSK 1011 N Arendell Ave Zebulon, NC 27597 Email david.x.schaeferaask.com Tel +1 919 269 1966 sg k.com I Twitter I YouTube I Facebook I Flickr GSK monitors email communications sent to and from GSK in order to protect GSK, our employees, customers, suppliers and business partners, from cyber threats and loss of GSK Information. GSK monitoring is conducted with appropriate confidentiality controls and in accordance with local laws and after appropriate consultation.